Chugai Pharmaceutical Co. Ltd.

CHGCY | OTC

Price Alert Chart Builder DCF Calculator

$21.64

+$0.08 (+0.37%)

Sep 22, 2026, 2:20 PM ET · Market open

Overview Rating Statistics Financials Earnings Ownership Dividends Profile

+0.37%

(1D)

Rating

Updated: Sep 14, 2026

7.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $71.23B

1D Range

21.60 22.10

52W Range

20 34.84

Valuation (TTM)

PE 26.79

PB 5.15

EV/EBITDA 15.61

Valuation (NTM)

Forward PE 17.80

Forward PEG 1.56

Price Target N/A

Cash Flow

FCF Yield 3.5%

SBC Adj. FCF Yield 3.5%

SBC Impact N/A

Margins

Gross Margin 71.4%

Operating Margin 45.6%

FCF Margin 33.1%

Growth (CAGR)

Revenue 3Y | 5Y -0.3% | 10.3%

Dil EPS 3Y | 5Y 0.5% | 15.7%

FCF 3Y | 5Y 5.3% | 29.7%

Returns

ROA 19.2%

ROE 24.0%

ROIC 22.2%

Financial Health

Net Cash

¥1.03T ($7.14B)

Current Ratio 4.35

Interest Coverage 652.57

Dividends

Div Yield 5.80%

Payout Ratio 1.0%

FCF Payout Ratio 40.8%

All Key Statistics

Loading financial charts...

Profile

A detailed description of the company is not yet available.

Sector n/a

Industry n/a

Employees n/a

IPO Date n/a

Website n/a

Fiscal Year n/a

Full Company Profile

Latest News

1 month ago · defenseworld.net

Short Interest in Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (OTCMKTS:CHGCY) Decreases By 54.9%

Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (OTCMKTS:CHGCY - Get Free Report) was the target of a large drop in short interest in the month of July. As of July 31st, there was short interest totaling 28,818 shares, a drop of 54.9% from the July 15th total of 63,921 shares. Currently, 0.0% of the shares of

2 months ago · seekingalpha.com

Chugai Pharmaceutical Co., Ltd. (CHGCY) Q2 2026 Earnings Call Transcript